Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$0.42 - $41.25 $9 - $907
22 New
22 $0
Q1 2022

May 16, 2022

BUY
$2.2 - $6.01 $807 - $2,205
367 Added 7340.0%
372 $1,000
Q4 2021

Feb 08, 2022

BUY
$6.0 - $9.92 $30 - $49
5 New
5 $0

Others Institutions Holding SRZN

About Surrozen, Inc.


  • Ticker SRZN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,122,900
  • Market Cap $365M
  • Description
  • Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...
More about SRZN
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.